The CADA-MRIT: An MRI Inventory Tool for Evaluating Cerebral Lesions in CADASIL Across Cohorts

Ruiting Zhang1, Chih-Hao Chen1, Sophie Tezenas Du Montcel1

  • 1From the Paris-Cité University (R.Z., J.L., H.C.), Inserm U1141 NeuroDiderot, France; Department of Radiology (R.Z.), the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China; Department of Neurology (C.-H.C., Y.-W.C., S.-C.T.), National Taiwan University Hospital, Taipei; Department of Clinical Neurosciences (C.-H.C.), University of Calgary, Alberta, Canada; Sorbonne Université (S.T.D.M.), Paris Brain Institute, INSERM, INRIA, CNRS, APHP; Lariboisière University Hospital (J.L., H.C.), APHP, Translational Neurovascular Centre and Department of Neurology, Reference Center for Rare Vascular Diseases of the Central Nervous System and the Retina (CERVCO), FHU NeuroVasc, Paris, France; Department of Neurology (Y.-W.C.), National Taiwan University Hospital Hsinchu Branch; Institute for Stroke and Dementia Research (M.D.), University Hospital, Ludwig Maximilian University, Munich; German Center for Neurodegenerative Diseases (DZNE) (M.D.), Munich; and Munich Cluster for Systems Neurology (SyNergy) (M.D.), Germany.

Neurology
|August 31, 2023
PubMed

Insights

A new tool, CADA-MRIT, simplifies MRI analysis for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). It reliably assesses key lesions, enabling cross-population comparisons of this genetic cerebrovascular disease.

Area of Science:

  • Neurology
  • Radiology
  • Genetics

Background:

  • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common inherited cerebrovascular disorder.
  • Significant variability exists in clinical presentation and MRI findings across different CADASIL patient cohorts.
  • Limitations in standardizing MRI acquisition hinder comparisons between studies and populations.

Purpose of the Study:

  • To develop and validate a user-friendly tool for rapid inventory of key MRI features in CADASIL.
  • To enable standardized comparison of imaging data across diverse patient populations and international cohorts.
  • To improve the consistency and comparability of MRI assessments in CADASIL research.

Main Methods:

  • The CADA-MRIT tool was developed through expert consensus, comprising 11 imaging items.
  • The tool assesses white matter hyperintensity (WMH), lacunes, cerebral microbleeds (CMB), dilated perivascular spaces (dPVS), atrophy, infarcts, and macrobleeds.
  • Reliability, clinical relevance, and time-effectiveness were evaluated using data from 671 patients across three independent cohorts (France, Germany, Taiwan).

Main Results:

  • CADA-MRIT scores for WMH, CMB, and dPVS demonstrated high reliability (weighted κ > 0.60) across different scanners and sequences.
  • Intrarater and interrater agreement for the tool were consistently good to very good (weighted κ > 0.60).
  • Global WMH and atrophy scores correlated strongly with volumetric measures, and imaging scores associated with clinical manifestations; assessment time was 2-3 minutes per patient.

Conclusions:

  • CADA-MRIT is a reliable, easy-to-use instrument for analyzing and comparing common MRI lesions in CADASIL.
  • The tool facilitates consistent imaging data comparison across different populations, scanners, and sequences.
  • CADA-MRIT provides clinically relevant scores efficiently, aiding research and clinical practice in CADASIL.
Abstract